MARKSANS

Marksans Pharma Share PriceMarksans Pharma

₹82.75
-1.45 (-1.72%)
As on 05 June, 2023 | 01:41 BSE: 524404 NSE: MARKSANS

Marksans Pharma Performance

Day Range

  • Low
  • High
82.75

52 Week Range

  • Low
  • High
82.75
  • Open Price
  • Previous Close
  • Volume

Start SIP in Marksans Pharma

Start SIP

Marksans Pharma Share Price

  • Over 1 Month 1.66%
  • Over 3 Month 22.87%
  • Over 6 Month 41.82%
  • Over 1 Year 75.5%

Marksans Pharma Key Statistics

P/E Ratio 14.1
PEG Ratio 0.3
Market Cap Cr 3,750
Price to Book Ratio 2.1
EPS 2.3
Dividend 0.3
Relative Strength Index 62.78
Money Flow Index 79.49
MACD Signal 0.52
Average True Range 3.34

Marksans Pharma Investment Rating

  • Master Rating:
  • Marksans Pharma has an operating revenue of Rs. 1,852.14 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 18% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 33% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Marksans Pharma Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 153173170159176
Operating Expenses Qtr Cr 130149136148149
Operating Profit Qtr Cr 2324341227
Depreciation Qtr Cr 44555
Interest Qtr Cr 11111
Tax Qtr Cr 59967
Net Profit Qtr Cr 1826401921

Marksans Pharma Technicals

EMA & SMA

Current Price
₹82.75
-1.45 (-1.72%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹77.78
  • 50 Day
  • ₹75.31
  • 100 Day
  • ₹71.13
  • 200 Day
  • ₹65.58
  • 20 Day
  • ₹76.56
  • 50 Day
  • ₹75.8
  • 100 Day
  • ₹70.85
  • 200 Day
  • ₹62.17

Marksans Pharma Resistance and Support

PIVOT
₹84.67
Resistance
First Resistance ₹86.04
Second Resistance ₹87.87
Third Resistance ₹89.24
RSI 62.78
MFI 79.49
MACD Single Line 0.52
MACD 1.57
Support
First Resistance ₹82.84
Second Resistance ₹81.47
Third Resistance ₹79.64

Marksans Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,630,204 105,681,597 40.18
Week 8,537,614 255,786,909 29.96
1 Month 3,021,633 112,102,567 37.1
6 Month 2,704,129 104,298,254 38.57

Marksans Pharma Result Highlights

Marksans Pharma Synopsis

NSE-Medical-Diversified

Marksans Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 655.20 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2023. Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364.
Market Cap 3,750
Sales 655
Shares in Float 25.38
No of funds 71
Yield 0.6
Book Value 3.37
U/D Vol ratio 2
LTDebt / Equity
Alpha 0.24
Beta 0.64

Marksans Pharma

Owner NameMar-23Jan-23Dec-22Sep-22
Promoters 43.85%43.8%49%48.6%
Mutual Funds 0.86%0.86%0.96%0.95%
Foreign Portfolio Investors 4.23%3.94%4.23%4.06%
Financial Institutions/ Banks
Individual Investors 34.42%35.19%39.69%39.76%
Others 16.64%16.21%6.12%6.63%

Marksans Pharma Management

Name Designation
Mr. Mark Saldanha Chairman & Managing Director
Mrs. Sandra Saldanha Whole Time Director
Mr. Varddhman V Jain Whole Time Director
Dr. Sunny Sharma Non Executive Director
Mr. Digant Mahesh Parikh Independent Director
Mr. Abhinna Sundar Mohanty Independent Director
Mr. Seetharama R Buddharaju Independent Director
Dr.(Mrs.) Meena Rani Surana Independent Director

Marksans Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Marksans Pharma Corporate Action

Date Purpose Remarks
2023-05-30 Audited Results & Final Dividend
2023-02-13 Quarterly Results
2023-01-20 Others Re.0.00 alia, to consider and approve allotment of fully paid-up Equity Shares having face value of Re. 1/- each against the convertible warrants on preferential basis.
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
Date Purpose Remarks
2023-06-07 FINAL Rs.0.50 per share(50%)Final Dividend

Marksans Pharma MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 4092
Motilal Oswal S&P BSE Healthcare ETF 6

Marksans Pharma FAQs

What is Share Price of Marksans Pharma ?

Marksans Pharma share price is ₹82 As on 05 June, 2023 | 01:27

What is the Market Cap of Marksans Pharma ?

The Market Cap of Marksans Pharma is ₹3749.9 Cr As on 05 June, 2023 | 01:27

What is the P/E ratio of Marksans Pharma ?

The P/E ratio of Marksans Pharma is 14.1 As on 05 June, 2023 | 01:27

What is the PB ratio of Marksans Pharma ?

The PB ratio of Marksans Pharma is 2.1 As on 05 June, 2023 | 01:27

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number